Erempharma Report issue

For profit Phase 2
Founded: Levallois-Perret France (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2010
NCT01288170
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

tobramycin (nebcin) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystic Fibrosis (Phase 2)

Fibrosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1